维普中文期刊产品整合服务
70篇 您的检索式:作者名="Andric"
    题名 作者 年代 出处 被引量
1Levels of insecticide resistance to deltamethrin,malathion,and temephos,and associated mechanisms in Aedes aegypti mosquitoes from the Guadeloupe and Saint Martin islands(French West Indies)显示文摘Background:In the Guadeloupe and Saint Martin islands,Aedes aegypti mosquitoes are the only recognized vectors of dengue,chikungunya,and Zika viruses.For around 40 years,malathion was used as a mosquito adulticide and temephos as a larvicide.Since the European Union banned the use of these two insecticide molecules in the first decade of the 21st century,deltamethrin and Bacillus thuringiensis var.israelensis are the remaining adulticide and larvicide,respectively,used in Guadeloupe.In order to improve the management of vector control activities in Guadeloupe and Saint Martin,we investigated Ae.aegypti resistance to and mechanisms associated with deltamethrin,malathion,and temephos.Methods:Ae.aegypti mosquitoes were collected from six different localities of Guadeloupe and Saint Martin.Larvae were used for malathion and temephos bioassays,and adult mosquitoes for deltamethrin bioassays,following World Health Organization recommendations.Knockdown resistance(Kdr)genotyping for V1016I and F1534C mutations,and expression levels of eight enzymes involved in detoxification mechanisms were examined in comparison with the susceptible reference Bora Bora strain.Results:Resistance ratios(RR50)calculated for Ae.aegypti larvae showed high resistance levels to temephos(from 8.9 to 33.1-fold)and low resistance levels to malathion(from 1.7 to 4.4-fold).Adult females displayed moderate resistance levels to deltamethrin regarding the time necessary to affect 50%of individuals,varying from 8.0 to 28.1-fold.Molecular investigations on adult mosquitoes showed high resistant allele frequencies for V1016I and F1534C(from 85 to 96%and from 90 to 98%,respectively),as well as an overexpression of the glutathione S-transferase gene,GSTe2,the carboxylesterase CCEae3a,and the cytochrome genes 014614,CYP6BB2,CYP6M11,and CYP9J23.Conclusions:Ae.aegypti populations from Guadeloupe and Saint Martin exhibit multiple resistance to organophosphates(temephos and malathion),and pyrethroids(deltamethrin).The mechanisms associated with these resistance patterns show strong frequencies of F1534C and V1016I Kdr mutations,and an over-expression of CCEae3a,GSTe2,and four cytochrome P450 genes(014614,CYP9J23,CYP6M11,CYP6BB2).These results will form the baseline for a deeper understanding of the insecticide resistance levels and associated mechanisms of Ae.aegypti populations and will be used to improve vector control strategies in Guadeloupe and Saint Martin.Daniella Goindin Christelle Delannay Andric Gelasse Cedric Ramdini Thierry Gaude Frederic Faucon Jean-Philippe David Joël Gustave Anubis Vega-Rua Florence Fouque 2017Infectious Diseases of Poverty2017,6,1:3
2Genetic basis of resistance to trauma in inbred strains of mice显示文摘Radojicic C Andric B Simovic M 1990J Trauma1990,30,2:2
3Myeloper oxidase acts as a profi- brotic mediator of atrial fibrillation显示文摘Rudolph V Andric RP Rudolph TK 2010Nat Med2010,16,:1
4Effects of substrate loading on enzymatic hydrolysis and viscosity of pretreated barley straw显示文摘Rosgaard L Andric P Dam-Johansen K 2007Applied Biochemistry and Biotechnology2007,,:1
5Functional endoscopic sinus surgery as an adjunctive treatment for closure of oroantral fistulae: a retrospective analysis 显示文摘Andric M Saranovic V Drazic R 2010Oral Surg Oral Med Oral Pathol Oral Radiol Endod2010,109,4:1
6Testosterone-induced modulation of Nitric Oxide-cGMP signaling pathway and androgenesis in the rat Lcydig cells显示文摘Andric SA Janjic MM Stojkov N J 2010Biol Reprod2010,83,3:1
7显示文摘Reza S DarS Andric T 1999Leuk Lymphoma1999,33,:1
8Hyperbaric oxygen dose of choice in the treatment of glaucoma显示文摘Bojid L Kovacevic H Andric D Romanovic D Petri NM 1993Arh Hig Rada Toksikol1993,44,3:1
9Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?显示文摘BACKGROUND The sodium/glucose cotransporter-2 inhibitors(SGLT-2i)and glucagon-like-1 receptor agonists(GLP-1RA)are antidiabetic agents effective both in hemoglobin A1c(HbA1c)reduction(with a low risk of hypoglycemia)and cardiovascular event prevention.In patients with type 2 diabetes,the add-on value of combination therapy of GLP-1RA and an SGLT-2i seems promising.AIM To investigate whether the efficacy of GLP-1RA and SGLT-2i combination observed in randomized controlled trials translates into therapeutic benefits in the Croatian population during routine clinical practice and follow-up.METHODS We included 200 type 2 diabetes patients with poor glycemic control and analyzed the effects of treatment intensification with(1)GLP-1RA on top of SGLT-2i,(2)SGLT-2i on top of GLP-1RA compared to(3)simultaneous addition of both agents.The primary study endpoint was the proportion of participants with HbA1c<7.0%and/or 5%bodyweight reduction.Secondary outcomes included changes in fasting plasma glucose(FPG),prandial plasma glucose,lowdensity lipoprotein cholesterol,estimated glomerular filtration rate(eGFR),and cardiovascular(CV)incidents assessment over a follow-up period of 12 mo.RESULTS The majority of patients were over 65-years-old,had diabetes duration for more than 10 years.The initial body mass index was 39.41±5.49 kg/m2 and HbA1c 8.32±1.26%.Around half of the patients in all three groups achieved target HbA1c below 7%.A more pronounced decrease in the HbA1c seen with simultaneous SGLT-2i and GLP-1RA therapy was a result of higher baseline HbA1c and not the effect of initiating combination therapy.The number of patients achieving FPG below 7.0 mmol/L was significantly higher in the SGLT-2i group(P=0.021),and 5%weight loss was dominantly achieved in the simultaneous therapy group(P=0.044).A composite outcome(reduction of HbA1c below 7%(53 mmol/mol)with 5%weight loss)was achieved in 32.3%of total patients included in the study.Only 18.2%of patients attained composite outcome defined as HbA1c below 7%(53 mmol/mol)with 5%weight loss and low-density lipoprotein cholesterol<2.5 mmol/L.There were no significant differences between treatment groups.No differences were observed regarding CV incidents or eGFR according to treatment group over a follow-up period.CONCLUSION Combination therapy with GLP-1RA and SGLT-2i is effective in terms of metabolic control,although it remains to be determined whether simultaneous or sequential intensification is better.Maja Cigrovski Berkovic Ines Bilic-Curcic Tomislav Bozek Davorka Herman Mahecic Sanja KlobucarMajanovic Silvija Canecki-Varzic Jelena Andric Srecko Marusic Anna Mrzljak 2020World Journal of Diabetes2020,11,11:1
10Fabrication and characterization of electrospun osteon mimicking scaffolds for bone tissue engineering 显示文摘Andric T Sampson AC Freeman JW 2011Mater Sci Eng C Mater Biol App2011,31,:1
11Synthesis of Y2SiO5:Eu^3+ nanoparticles from a hydrothermally prepared silica sol显示文摘Dramicanin M D Viana B Andric Z 2008Journal of Alloys and Compounds2008,464,12:1
12Hyperbaric oxygen as a method of therapy of sudden sensorineural hearing loss 显示文摘RACIC G PETRI N M ANDRIC D 2001Int Marit Health2001,52,14:1
13Effects of substrate loading on enzymatic hydrolysis and viscosity of pretreated barley straw显示文摘Rosgaard L Andric P Dam-Johansen K 2007Applied Biochemistry and Bioteehnology2007,143,1:1
14Hyperbaric oxygen as a method of therapy of sudden sensorial neural hearing loss显示文摘Racic G Pet ri NM Andric D 0,,:1
15Hyperbaric oxygen as a method of therapy of sudden sensorineural hearing loss显示文摘Racie G Petri NM Andric D 2001International Maritime Health2001,51,:1
16Nitric oxide- scavenging activity of polyhydroxylated fullerenol, C60 (OH)24显示文摘Mirkov SM Djordjevic AN Andric NL 2004Nitric Oxide2004,11,2:1
17Effects of substrate loading on enzymatic hydrolysis and viscosity of pretreated barley straw 显示文摘Lisa Rosgaard Pavle Andric Kim Dam-Johansen 2007Applied Biochemistry and Biotechnology2007,143,1:1
18Hyperbaric oxygen as a method of therapy of sudden sensorineural hearing loss显示文摘Racic G Petri NM Andric D 2001Int Marit Health2001,52,14:1
19In vivo and in vitroeffects of PCB126 and PCB153 on rat testicular androgenesis 显示文摘Andric N Kostic T Kaisarevic S 2008Environ Toxicol Pharmacol2008,25,2:1
20显示文摘Andric S 2000Biol Reprod2000,62,6:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费